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Abstract
Background: CRF14_BG isolates, originally found in Spain, are characterized by CXCR4 tropism and rapid disease
progression. This study aimed to identify the origin of CRF14_BG and reconstruct its epidemiological history based on new
isolates from Portugal.
Methodology/Principal Findings: C2V3C3 env gene sequences were obtained from 62 samples collected in 1993–1998
from Portuguese HIV-1 patients. Full-length genomic sequences were obtained from three patients. Viral subtypes, diversity,
divergence rate and positive selection were investigated by phylogenetic analysis. The molecular structure of the genomes
was determined by bootscanning. A relaxed molecular clock model was used to date the origin of CRF14_BG. Geno2pheno
was used to predict viral tropism. Subtype B was the most prevalent subtype (45 sequences; 73%) followed by CRF14_BG (8;
13%), G (4; 6%), F1 (2; 3%), C (2; 3%) and CRF02_AG (1; 2%). Three CRF14_BG sequences were derived from 1993 samples.
Near full-length genomic sequences were strongly related to the CRF14_BG isolates from Spain. Genetic diversity of the
Portuguese isolates was significantly higher than the Spanish isolates (0.044 vs 0.014, P,0.0001). The mean date of origin of
the CRF14_BG cluster was estimated to be 1992 (range, 1989 and 1996) based on the subtype G genomic region and 1989
(range, 1984–1993) based on the subtype B genomic region. Most CRF14_BG strains (78.9%) were predicted to be CXCR4.
Finally, up to five amino acids were under selective pressure in subtype B V3 loop whereas only one was found in the
CRF14_BG cluster.
Conclusions: CRF14_BG emerged in Portugal in the early 1990 s soon after the beginning of the HIV-1 epidemics, spread to
Spain in late 1990 s as a consequence of IVDUs migration and then to the rest of Europe. CXCR4 tropism is a general
characteristic of this CRF that may have been selected for by escape from neutralizing antibody response.
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Introduction
By the end of 2009, the estimated number of adults and children
living with HIV/AIDS in Portugal was 42,000 (32,000–53,000)
[1]. The HIV/AIDS prevalence was 0.6% (0.4%–0.7%) in the
adult population, one of the highest in Western Europe [1]. After
an initial period dominated by homosexual transmission of HIV-1,
a shift towards transmission through heterosexual contacts and
drug injection occurred and, today, heterosexual contact is the
main route of HIV-1 transmission in Portugal [2]. African and
Brazilian immigrants contribute substantially for the number of
AIDS cases in this category [2].
The current HIV-1 epidemic in Portugal is caused by multiple
subtypes, with predominance of subtype B (41.7%) followed by G
(29.4%) [3,4]. The high prevalence of these two subtypes has
promoted the appearance of different types of B/G recombinant
strains [4,5,6,7,8,9]. CRF14_BG was the first epidemic CRF
composed of subtypes B and G to be characterized by full-genome
sequencing. This CRF was first isolated in 2002 from intravenous
drug users (IVDUs) in Galiza, Spain [10]. CRF14_BG displays a
mosaic structure with two inter-subtype breakpoints delimiting a B
subtype segment comprising most of gp120 and the 59 half of
gp41, whereas all remaining regions are classified as subtype G
[10]. So far, only seven CRF14_BG isolates have been
characterized by full-genome sequencing. These were obtained
from Spanish (5/7, 71%), Portuguese (1, 14%) and German (1,
14%) IVDUs patients [10,11]. Until 2007, several sub-genomic
sequences related to CRF14_BG were reported in Germany (1),
Italy (2), United Kingdom (2), Estonia (15), Spain (38) and
Portugal (50) suggesting that this CRF spread efficiently through-
out Europe [4,6,7,8,11,12,13,14,15,16,17,18,19,20,21,22]. How-
ever, in recent years very few mentions have been made to this
CRF in Europe suggesting that its prevalence has reduced
significantly [23]. Striking and unique features of most isolates
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belonging to this CRF are their CXCR4 tropism and association
with rapid CD4+ T cell depletion and disease progression
[20,21,23,24].
To better understand the epidemiology of CRF14_BG we have
characterized the full-length genome of three new CRF14_BG
isolates obtained from three Portuguese patients infected in 1997,
dated the origin of this CRF and reconstructed its evolutionary
history. Moreover, to trace back the epidemiological history of this
virus, env gene sequences were obtained from 62 patients infected
in Portugal between 1993 and 1998. Finally, to gain some insight
into the selective forces promoting CXCR4 usage by isolates
belonging to this CRF, we have used genetic methods to
determine the tropism of a significant number of recent
Portuguese isolates and phylogenetic methods to investigate
positive selection in the V3 region. Our results indicate that
CRF14_BG originated in Portugal in the beginning of the HIV-1
epidemics. From here, it probably spread to Galiza, Spain, in late
1990 s and to other countries in Europe in early 2000. Our results
confirm that the CXCR4 tropism is a general and stable feature of
CRF14_BG and suggest that this phenotype might be a
consequence of successful escape from neutralizing antibody
response.
Results
Molecular epidemiology of partial and near full-length
HIV-1 sequences
Phylogenetic analysis showed that HIV-1 C2-C3 sequences
belonged to different subtypes (Figure 1). As expected, subtype B
was the most prevalent subtype (45 sequences; 73%) followed by
CRF14_BG (8; 13%), G (4; 6%), F1 (2; 3%), C (2; 3%) and
CRF02_AG (1; 2%). Importantly, three CRF14_BG sequences
were derived from 1993 samples. These results suggest that
CRF14_BG was already circulating in Portugal in 1993.
Near full-length genomic sequences were obtained from three
HIV-1 infected patients residing in Lisbon. These were two
children (00PTHSM5, 00PTHDE10) infected by vertical trans-
mission in 1997 and one young adult (98PTHEM103) infected by
heterosexual contact in the same year (Table 1) [24]. Bootscan
analyses revealed that the new isolates share a mosaic structure
that is similar to the reference CRF14_BG strains with only two
intersubtype breakpoints delimiting a B subtype segment
comprising most of gp120 and the 59 half of gp41 and the
remaining portions of the genome of subtype G (Figure 2).
Phylogenetic analyses revealed that the different sub-genomic
sequences were strongly related with reference CRF14_BG
isolates from Spain.
CRF14_BG originated in Portugal in early 1990 s
The mean date of origin of the CRF14_BG cluster was estimated
to be 1992 (range 1989 and 1996) based on the subtype G genomic
region and 1989 (1984–1993) based on the subtype B genomic
region (Figure 3). The Portuguese CRF14_BG genome sequences
were not monophyletic, but clustered with Spanish CRF14_BG
sequences. Therefore, no discrimination could be made between the
time of entry of this CRF in Portugal and in Spain. Notably, two
full-length subtype G sequences from Spain (G.ES.00.X558 and
G.ES.99.X138) clustered within the CRF14_BG cluster, indicating
a possible subtype G ancestor for this CRF.
On the other hand, despite a similar divergence rate to the
MRCA between Portuguese and Spanish isolates (0.030 substitu-
tions per site vs 0.024, P = 0.2857) the genetic diversity between
Portuguese isolates was significantly higher than between the
Spanish isolates (0.044 vs 0.014, P,0.0001). CRF14_BG isolates
from Portugal were found in all transmission groups and some
partial env CRF14_BG-like sequences were obtained from
samples collected back in 1993 whereas original Spanish
CRF14_BG isolates were all obtained in 2000 from IVDUs.
These data is consistent with a long standing presence of this CRF
in Portugal and suggest that CRF14_BG originated in Portugal
rather than in Spain.
Most CRF14_BG isolates use CXCR4
Geno2pheno predicted that most (15/19; 78.9%) recombinant
Gpol/Benv sequences (corresponding to the full-genome
CRF14_BG sequences recombination pattern) used CXCR4,
while only 4 used CCR5. Notably, the phylogenetic tree of the
recombinant BG sequences and control subtype B sequences from
the Portuguese and Los Alamos database indicated a cluster of
CXCR4 using sequences that included 14 of the BG sequences
that used CXCR4 together with 3 other subtype B control
sequences that also used CXCR4 and only 2 CCR5 using BG
recombinants (cluster had 19 sequences, of which 17 used
CXCR4, 89.5%, LRT value of the cluster = 0.98) (Figure 4). If
we extend the cluster backwards, we find a 25 sequences cluster
(subtype B and recombinant BG) of which 23 use CXCR4 (92%,
LRT = 0.82). In no other cluster of the tree did we identify such a
high proportion of CXCR4 using strains, indicating that there
may be something innate in these sequences that make them
evolve to using CXCR4 more frequently than other sequences.
Figure 1. Phylogenetic analysis of Env gene sequences from HIV-1 infected patients. The maximum likelihood phylogenetic trees were
constructed with reference sequences from all HIV-1 subtypes. The bootstrap values supporting the internal branches defining a subtype or a CRF are
shown. Bootstrap values of 70% or greater provide reasonable confidence for assignment of an individual segment to one or the other genotype. The
scale represents number of base substitutions per site.
doi:10.1371/journal.pone.0024130.g001
Table 1. Epidemiological characterization of CRF14_BG infected patients.
Sample Gender Ethnic group Year of infection Transmission route GeneBank accession number
00PTHSM5 F Caucasian 1997 MTCT GU230138
00PTHDE10 M Caucasian 1997 MTCT GU230137
98PTHEM103 M Caucasian 1997 Heterosexuala GU230139
MTCT - mother to child transmission;
aIndividual infected by sexual contact with HIV infected female sex worker which was intravenous drug user [24].
doi:10.1371/journal.pone.0024130.t001
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Positive selection might explain the evolution to CXCR4
usage in CRF14_BG isolates
We analyzed selective pressure both in the full tree and in the
BG recombinants cluster. The selective pressure analysis of the
complete tree consistently identified in the two models positive
selection in amino acid 11 of the V3 loop, which is a main
determinant of co-receptor usage (Table 2) [25,26]. Amino acids
20 and 35 were also consistently identified as being positively
selected. Furthermore, the SLAC method also indicated amino
acids 21 and 23 of V3 as being under positive selective pressure
and the dual variable rates model further indicated amino acid 26.
When we analyzed only the BGs subtree (19 sequences), we found
no evidence of positive selection in V3 when using the SLAC
model while when using the dual variable rates model the amino
acid 22 was indicated as being positively selected (Table 2).
Discussion
We provide new molecular and epidemiologic evidence
suggesting that CRF14_BG emerged in Portugal in the early
1990 s soon after the beginning of the HIV-1 epidemic. This was
surely a direct consequence of the early co-circulation of subtypes
B and G among the HIV-1 infected population. In fact, we show
here that three CRF14_BG-like isolates were already present in
Lisbon in 1993. Definitive proof of the early presence of
CRF14_BG in Portugal was obtained by genomic sequencing of
three isolates obtained from patients infected in 1997 and
representing the two most important transmission groups (vertical
and heterosexual transmission). Molecular clock analysis indicated
that the ancestor of the Portuguese CRF14_BG viruses dates back
to the early 90 s. The early presence of CRF14_BG in these
transmission groups implies that it was rapidly converted into a
highly successful epidemic strain.
CRF14_BG was found in Galiza, Spain, in 2002 among HIV-1
infected IVDU patients of Spanish (5 patients) and Portuguese (1
patient) origin [10]. Between 1999 and 2007 CRF14_BG-like
strains were found abundantly in Portugal, Spain and other
European countries [3,4,6,8,11,12,13,14,15]. In Portugal, in 2003,
CRF14_BG prevailed over all other recombinants [6,8]. Since
then, however, CRF14_BG prevalence decreased significantly in
Portugal [3,9] and Spain [23] and, to our knowledge, it has not
been reported elsewhere in the world. One reason for this decrease
in prevalence of CRF14_BG might be related with its high
tendency for recombination with other subtypes or recombinant
forms. This is suggested by the multiple CRF14_BG-like sub-
genomic fragments that have been described in the recent
literature [9,18] and by the existence of at least three other BG
intersubtype CRFs (CRF20_BG, CRF23_BG and CRF24_BG)
[27].
Alternatively, CRF14_BG prevalence may have decreased due
to its unusually high pathogenicity. We show here that most
CRF14_BG isolates circulating in Portugal form a single cluster
and use the CXCR4 co-receptor. The majority of CRF14_BG
isolates from Spain also use CXCR4, even those obtained from
patients at early stages of infection [20,21,23]. In subtype B
infected subjects, baseline infection with a CXCR4-using virus is
strongly associated with a greater decrease in CD4+ T cell count
over time and a greater risk of disease progression [28,29,30].
Consistent with this, a rapid decrease in CD4+ T cell counts has
been observed in all patients infected with CRF14_BG isolates
[21]. Moreover, we have shown recently that CRF14_BG infected
patients can progress very quickly to AIDS and death [24]. Taken
together, these results provide strong argument to suggest that, like
HIV-1 subtype D, CRF14_BG may be highly pathogenic [31,32].
We show that positive selection acts differently in the V3 loop of
CRF14_BG isolates compared to B isolates. In fact, between 0–1
amino acids are under selective pressure in CRF14_BG V3 loop
whereas in subtype B these are 4–5. Of particular interest in this
context was the finding that amino acid 11 in the V3 loop, which is
a main determinant of co-receptor usage [25,26], was not under
selective pressure in the CRF14_BG cluster of viruses. These
findings suggests that strong conformational and/or functional
constrains prevent changes in the V3 loop of this CRF and implies
that the CXCR4 tropism is a stable phenotypic feature of
CRF14_BG isolates. Neutralizing antibodies are the main selective
forces acting on the HIV-1 envelope and escape from these
antibodies can promote rapid envelope evolution [33,34]. CXCR4
tropism has been associated with escape from neutralizing
antibody response both in HIV-1 infection and HIV-2
[35,36,37]. Hence, CXCR4 tropism in CRF14_BG might have
been a direct consequence of successful escape from neutralization
in infected subjects. In this context, it is important to note that the
only R5 CRF14_BG isolate described so far was found in a
individual that progressed to AIDS and death in only 7 months
without producing HIV antibodies (seronegative infection) [24].
In conclusion, CRF14_BG probably emerged in Portugal in the
early 1990 s soon after the beginning of the HIV-1 epidemics and
spread to Galiza, North of Spain, in late 1990 s as a consequence
of the mobility of HIV-1 infected IVDUs. Until 2007 CRF14_BG
spread efficiently in Europe and elsewhere and from then on there
was a significant decrease in its detection. CXCR4 tropism is a
unique characteristic of this CRF that may have been selected for
by escape from neutralizing antibody response. The reasons for
the current low prevalence of this CRF remain unknown but may
be related with high recombination rate with other subtypes or
recombinant strains and/or with unusually high virulence and
pathogenicity.
Materials and Methods
Sample collection and sequencing
HIV-1 blood samples were collected from 62 HIV-1 patients
infected between 1993 and 1998 in the North (Porto) and South
(Lisbon) of Portugal. Viral genomic RNA was extracted from
plasma and reverse transcribed. A nested PCR technique was used
to amplify a 409 pb HIV-1 C2-C3 env region as described
elsewhere [38]. PCR products were sequenced using the BigDye
Terminator Cycle sequencing kit (Applied Biosystems), and an
automated capillary sequencer (ABI PRISM 310, Applied
Biosystems). Three patients residing in the Lisbon, two children
infected by vertical transmission and one adult infected by
heterosexual contact, all infected in 1997, were selected for full-
length genomic sequencing (Table 1). For this study, chromosomal
DNA was extracted from post-mortem tissue (patient 98PTHEM103)
or from peripheral blood mononuclear cells (00PTHSM5,
00PTHDE10) using a universal extraction method as described
Figure 2. Bootscanning analysis of full-length genomes from Portuguese and Spanish CRF14_BG isolates. The dashed line indicates the
cut-off of 70%. The maximum likelihood phylogenetic trees were constructed with reference sequences from all HIV-1 subtypes. The bootstrap values
supporting the internal branches defining a subtype or a CRF are shown. Bootstrap values of 70% or greater provide reasonable confidence for
assignment of an individual segment to one or the other genotype. The scale represents number of base substitutions per site.
doi:10.1371/journal.pone.0024130.g002
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Figure 3. Maximum Clade Credibility Tree for the subtype G and subtype B genomic regions of the CRF14_BG. The 95% confidence
interval for the date of origin of CRF14_BG is indicated in both trees as a grey square. Node values indicate its time of origin. Sequence names are
coded as [Subtype].[Country].[Seqname]_[Year of Sampling].
doi:10.1371/journal.pone.0024130.g003
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elsewhere [39]. Full-genome PCR amplification and sequencing
was done as described elsewhere [40].
Subtyping of HIV-1 sequences
The genomic sequences were aligned with reference sequences
obtained from the Los Alamos HIV Sequence Database using
Clustal-X [22] and manual adjustments were made using Genedoc
[41]. To confirm recombination events and identify recombina-
tion breakpoints, bootscanning analysis was performed using
Simplot 3.5.1 [42]. Maximum likelihood analyses [43] were
performed using the best-fit models of molecular evolution as
estimated by Modeltest under the Akaike information criterion [44].
These were the TVM model for the full-genome sequences and
TVM+G+I for the C2-C3 sequences. Tree searches were
conducted in PAUP v4.0b10 using a nearest-neighbor interchange
heuristic search strategy and bootstrap.
Dating the origin of CRF14_BG
To date the origin of CRF14_BG, two non-recombinant
regions of the genome were used (1442–4281 bp relative to
HXB2 - subtype G genomic region; 6417–8215 bp relative to
HXB2 –subtype B genomic region). Sequences collected from the
Los Alamos database (http://www.hiv.lanl.gov/) were aligned to
our 3 new full-genome CRF14_BG sequences. The Los Alamos
sequences included 4 CRF14_BG sequences from Spain and
Denmark (14_BG.DE.01.9196_01, 14_BG.ES.00.X605, 14_BG.
ES.00.X605 and 14_BG.ES.99.X397). Furthermore, for the
subtype G genomic region, 10 subtype G sequences were included
(G.ES.00.X558, G.ES.99.X138, G.BE.96.DRCBL, G.CM.01.
01CM_4049HAN, G.CM.96.96CMABB55, G.FI.93.HH8793_
1_1, G.NG.92.92NG083, G.NG.x.01NGPL0669, G.NG.x.
01NGPL0760 and G.SE.93.SE6165); while for the subtype B
genomic region, 22 subtype B sequences were included (B.FR_
IIIB_1983, B.US_ARES2_1997, B.US_Ba_L_1985, B.US_US2_
1991, B.FR_NL436WC001_1985, B.AU_MBC18_1993, B.ES_
S61D15_1989, B.AR_ARMS008_2000, B.BO_BOL0122_1999,
B.CN_CNHN24_2001, B.CA_WC10C_1_1996, B.US_1018_10_
1997, B.US_1058_11_1998, B.NL_671_00T167_2000, B.DK_
CTL_033_2001, B.ES_X2231_2007, B.HT_05HT_129389_
2005, B.ES_ES_2008, B.ES_H1_5p11_1989, B.FR_HXB2_1983,
Figure 4. Phylogenetic tree for the C3-V3 genomic region of the recombinant BG sequences, sequences downloaded from the Los
Alamos database and from Portuguese patients, showing the significant clustering of BG sequences and associated CXCR4 usage.
Sequences are labeled according to subtype and coreceptor usage, Sequences were either subtype G in pol and subtype B in env (circles), subtype B
both in pol and in env (squares). If the sequences were subtype B only in env (no information available for pol), no label was added. Sequences
colored green use CCR5 only, while sequences colored red can use CXCR4. Asterisk indicates significant support for the cluster (LRT .0.95). Tree was
built as described in the methods section.
doi:10.1371/journal.pone.0024130.g004
Table 2. Positive selective pressure on the V3 loop of the analysed dataset.
Codons under selective pressure1
Method Whole Tree (Bs+BGs) (Number of sequences in cluster = 201) BGs cluster (Number of sequences in cluster = 19)
SLAC 11, 20, 21, 23 and 35 None
Dual variable rates 11 , 20, 26 and 35 22
1Codons identified by Hyphy as being significantly (P,0.05) under selective pressure are indicated.
doi:10.1371/journal.pone.0024130.t002
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B.GB_GB8_1986 and B.NL_3202A21_1986). The estimation of
the date of origin of the tMRCA of CRF14_BG_was performed
using BEAST v1.5 [45]. The model of evolution used was HKY85
with a 4 class gamma distribution to model rate variation among
sites and allowing for a proportion of invariable sites. A relaxed
molecular clock model implemented under a flexible demographic
model (Bayesian skyline plot) was used to date the origin of
CRF14_BG as described previously [46]. A prior uniform
distribution was set for the date of origin of the phylogeny with
a uniform interval between 1901 and 1998. Two BGs clusters –
one including only Portuguese CRF14_BG sequences and another
including both Portuguese and Spanish CRF14_BG sequences –
were defined. These were given uniform prior distributions for the
root of the clade between 1931 (the date of origin of HIV-1 as
published by Korber et al [47]) and 1998 (1998 was the date of
sampling of the oldest sampled CRF14_BG sequence, indicating
that the recombinant certainly existed in that year).
Co-receptor usage, selective pressure and divergence
rates estimation
Pairwise genetic distances and divergence rates of Portuguese
and Spanish CRF14_BG isolates were calculated as described
previously [48].
For coreceptor usage analysis, we included new partial env
sequences in our alignments. The alignments now spanned the
C3-V3 region and included 201 sequences. These were sequences
collected either from the Los Alamos database or sequences from
Portuguese patients collected for the purpose of coreceptor usage
determination before starting Maraviroc treatment [9]. If a patient
had a subtype G sequence from pol and a subtype B sequence from
env, it was classified as a BG recombinant (circles in Figure 3). If a
patient had a subtype B sequence both in pol and env, it was
classified as a pure subtype B (squares in Figure 3). For the patients
collected from the Los Alamos database, sometimes there were
only subtype B sequences in env; these sequences were left
unclassified (taxa not marked with circles nor squares in Figure 3).
In total, 201 sequences were included in the alignment, of which
19 corresponded to BG recombinants, 114 were pure subtype B
(subtype B in pol and env) and the remaining were Los Alamos
subtype B sequences only in env (subtype B in env, but unknown
subtype for pol).
Co-receptor usage prediction of each sequence was made using the
geno2pheno software [49], after codon-aligning the C3-V3 genomic
region with the GeneCutter tool available at the Los Alamos website
(http://www.hiv.lanl.gov/content/sequence/GENE_CUTTER/
cutter.html).
The estimation of the underlying phylogenies for the estimation
of selective pressure was made with the PhyML software, using the
HKY85 substitution model with gamma distributed rate variation
and a proportion of invariant rates. The tree improvement was
made using the subtree-pruning regrafting (SPR) heuristic search.
The reliability of each cluster was determined using the likelihood
ratio test (LRT) method as implemented in PhyML. Finally, site-
by-site selective pressure was calculated using different models
available at the HyPhy package. We started by using the simple
single likelihood ancestor counting method (SLAC), a counting
method that employs maximum likelihood ancestral reconstruc-
tions. Then, we applied a more complex dual variable rates model,
with the MG946HKY85 codon rate matrix and dual variable dS
and dN rates drawn from bivariate independent discrete
distributions, with 4 rate classes.
Statistical analysis
Statistical analysis was performed in GraphPad Prism version
4.0 for Windows (GraphPad Software), with a level of significance
of 5%. Pairwise genetic distances and divergence rates were
compared using the Mann Whitney U test.
GenBank accession numbers
Sequences have been assigned GenBank accession numbers
GU230137 - GU230139 (full-length genomic sequences) and
EU335962 - EU335903 (C2-C3 sequences).
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